Clinical Trial Update: First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation [NA]

View source ↗

Summary

First-in-man early feasibility study of transcatheter septal ablation for hypertrophic obstructive cardiomyopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Obstructive Cardiomyopathy

Snippet

Sponsor: Tau-MEDICAL Co., Ltd. | Conditions: Hypertrophic Obstructive Cardiomyopathy | NA | Status: TERMINATED